Difficulty differentiating primary mediastinal classical Hodgkin lymphoma from inflammatory myofibroblastic tumor: A case report

Thorac Cancer. 2024 Feb;15(5):410-414. doi: 10.1111/1759-7714.15197. Epub 2023 Dec 30.

Abstract

A 20-year-old Japanese man visited our hospital because an enlarged mediastinal shadow had been detected on chest x-ray. Chest computed tomography revealed a large mediastinal mass with multiple lymph node enlargement, pericardial effusion, and bilateral pleural effusion. He was diagnosed with inflammatory myofibroblastic tumor (IMT) based on a thoracoscopic tumor biopsy. Initial corticosteroid and celecoxib treatment was only partially effective; therefore, additional tumor rebiopsy and left axillary lymph node biopsy were performed. Based on the findings, the patient was rediagnosed with classical Hodgkin lymphoma (CHL). To date, there has only been one report of a case initially diagnosed as IMT and rediagnosed as CHL, as in our case, and only three reports of malignant lymphoma mimicking IMT. When IMT is suspected based on pathological findings and subsequently with treatment failure, possible CHL and performing rebiopsy should be considered.

Keywords: Hodgkin lymphoma; inflammatory myofibroblastic tumor; malignant lymphoma.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Biopsy
  • Hodgkin Disease* / diagnosis
  • Hodgkin Disease* / drug therapy
  • Hodgkin Disease* / pathology
  • Humans
  • Lymph Nodes / pathology
  • Lymphoma*
  • Male
  • Thorax / pathology
  • Young Adult